Chauhan PK, Upadhyay SK, Tripathi M, Singh R, Krishna D, Singh SK, Dwivedi P (2023) Understanding the salinity stress on plant and developing sustainable management strategies mediated salt-tolerant plant growth-promoting rhizobacteria and CRISPR/Cas9

The evidence now is reassuring: A 2025 meta-analysis in JAMA Psychiatry found no increase in depression or suicidality with GLP-1 medications versus placebo FDA and EMA reviews found no causal link between GLP-1s and suicidal behavior In fact, GLP-1-treated groups showed slightly lower rates of depressive symptoms in clinical trials (likely due to improved metabolic health and quality of life) Potential mental health benefits under investigation: Reduced binge-eating impulses Decreased cravings in substance use disorders Improved mood independent of weight loss (possibly via reduced inflammation and effects on brain reward circuits) Bottom line: With appropriate monitoring, psychiatrists can feel confident that adding a GLP-1 wont destabilize a patients mental state and may improve it
The gastrointestinal side effects of Rybelsus typically diminish over time as the body adapts to the medication
Liraglutide: from clinical trials to clinical practice
Beginner, moderate, and aggressive